Natco Pharma Limited — Others, 13-08-2025: Copy of Newspaper Publication

Natco Pharma has announced a board meeting held on August 12, where it approved the financial results for the quarter ended June 30, 2025, following the Audit Committee's review. Additionally, the Board declared an interim dividend of Rs. 2.50 per equity share. Shareholders on record as of August 19, 2025, will be eligible for this dividend, with payments commencing from August 20, 2025. These announcements provide key updates on the company's financial performance and direct returns to shareholders, which are crucial for retail investors.